Sulfoximines as potent RORγ inverse agonists. - Ouvry G; Bihl F; Bouix-Peter C; Christin O; Defoin-Platel C; Deret S; Feret C; Froude D; Hacini-Rachinel F; Harris CS; Hervouet C; Lafitte G; et al. (Bioorganic & medicinal chemistry letters, 2018)